Supplemental Disclosure of Cash Flow Information

6 Months Ended

Jun. 30, 2021

Supplemental Cash Flow Elements [Abstract]

Supplemental Disclosure of Cash Flow Information

Note 12 – Supplemental Disclosure of Cash Flow Information

	Six Months Ended June 30,
	2021		2020
Cash paid for interest	$	-	$	9,455
Cash paid for income taxes	$	281,025	$	-
Non-cash investing and financing activities:
Preferred stock of VisualMED received from the sale of HTS and AMSG	$	8,500,000	$	-
Net liabilities of HTS and AMSG transferred to VisualMED		2,227,152		-
Series I-2 Preferred Stock converted into common stock		-		25,000
Exchange of Series K Preferred Stock for Series L Preferred Stock		-		(2,500	)
Issuance of Series L Preferred Stock		-		2,500
Issuance of Series M Preferred Stock in exchange for related party loans and accrued interest		-		22,000,000
Loans and accrued interest exchanged for Series M Preferred Stock		-		18,849,632
Deemed dividend from exchange of loans and accrued interest for Series M Preferred Stock		-		3,150,368
Series M Preferred Stock converted into common stock		619,650		-
Series N Preferred Stock converted into common stock		13,065,527		-
Deemed dividends for trigger of down round provisions		149,611,479		-
Original issue discounts on debt		27,630		63,695